BioNTech SE (BNTX) Leases (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Leases data on file, last reported at $244.7 million in Q4 2025.

• In Q4 2025, Leases fell 7.71% year-over-year to $244.7 million; the TTM figure through Dec 2025 stood at $244.7 million (down 7.71% YoY), while the FY2025 annual figure was $237.5 million, down 10.42% from the prior year.
• Leases rose to $244.7 million in Q4 2025, from $235.0 million in the prior quarter.
• Across five years, Leases topped out at $276.1 million in Q2 2024 and bottomed at $142.8 million in Q1 2021.
• A 5-year average of $237.5 million and a median of $239.8 million in 2025 frame the typical range for Leases.
• Annual changes were most pronounced in 2021 — Leases soared 91.8% — and 2023, when it dropped 21.8%.
• Year by year, Leases stood at $226.4 million in 2021, then decreased by 4.51% to $216.2 million in 2022, then rose by 6.7% to $230.7 million in 2023, then increased by 14.93% to $265.1 million in 2024, then dropped by 7.71% to $244.7 million in 2025.
• The last three Leases figures came in at $244.7 million (Q4 2025), $235.0 million (Q3 2025), and $253.9 million (Q2 2025), per Business Quant data.

Peer Comparison